ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Shareholders Information
Live Quote
 
 

2011

Please see the folder "General Meeting Documentation" under the Investor Relations section for information on the forthcoming General Meetings and all documentation in relation to AGM's from January 2011 onwards.

Research:-
ValiRx Plc's or 'The Company' house broker, Hybridan LLP, will from time to time publish research notes from this page.  Any opinions, estimates or forecasts regarding The Company's performance made by the brokers are theirs alone and do not represent opinions, forecasts or predictions of The Company or its Management.  By distributing the information below The Company does not imply its endorsement of or concurrence with such information.     

Please click here to view the ValiRx Research Note - 17 May 2011.

Please click here to view ValiRx Plc's Corporate Presentation.

ValiRx Plc - Latest News and Video Release - 18 May 2011:-

Satu Vainikka, from Valirx, talks about the unlimited potential of
GeneICE"

"Dr Satu Vainikka, CEO at Valirx (LON:VAL), tells Proactive Investors
that there is tremendous potential for its GeneICE programme Satu
believes that the recently raised £3.3mln will see Valirx through to
pre-clinical studies at which point it is likely that a commercial joint
venture partner will be found within the sector."

Proactiveinvestors UK:
http://www.proactiveinvestors.co.uk/companies/stocktube/760/satu-vainikka-
from-valirx-talks-about-the-unlimited-potential-of-geneice-.html

You will also find this published on:
Google News: 
http://www.google.com/news/search?aq=f&pz=1&cf=all&ned=uk&hl=en&q=ValiRx

Google Finance: http://www.google.com/finance?q=LON:VAL

News Now: http://www.newsnow.co.uk/h/?JavaScript=1&search=ValiRx

One News Page: http://www.onenewspage.com/topic/ValiRx.htm

Silobreaker: http://www.silobreaker.com/Search.aspx?q=ValiRx&rd=true

Moreover Technologies:
http://w.moreover.com/public/free-rss/rss-feeds.html?query=%22ValiRx%22

Wotnews: http://wotnews.com.au/news/?search_state=&search_query=ValiRx

You will also shortly find this news disseminated across our social
networking sites here:

Twitter: 
http://twitter.com/proactive_uk

Facebook: 
http://www.facebook.com/pages/Proactive-Investors/163845340310506

Blogspot.com: http://proactiveinvestors.blogspot.com/

Seeking Alpha: http://seekingalpha.com/author/proactive-investor/instablog

Word Press: http://proactiveinvestors.wordpress.com/

 

2010

Please click here to view the ValiRx Research Note/Initiating Coverage - 11 November 2010.

Please see the folder "General Meeting Documentation" under the Investor Relations for information on the forthcoming Annual General Meeting in June 2010 and the Financial Accounts Year Ended 31 December 2009.

General Meeting Result April 2010

Notice of General Meeting April 2010

 

2009   

General Meeting Results December 2009

Chairman's Letter December 2009   

Notice of General Meeting December 2009    

AGM Result 2009   

AGM Notice July 2009   

General Meeting Result 2009   

Chairman's Letter 2009   

Notice of General Meeting February 2009   

 

2008    

ValiRx held its last Annual General Meeting on 28 July 2008 in London. The notice together with the Chairman's letter have been sent to shareholders and are also available for download by clicking below    

AGM Result 2008  

AGM Notice 2008   

Form of Proxy 2008   

General Meeting Result 2008   

Chairman's Letter 2008   

Notice of General Meeting 2008   

2007    

ValiRx held its first Annual General Meeting on 27th July 2007 in London. The notice of AGM together with the financial accounts for 2006 have been sent to shareholders and are also available for download by clicking on the links in PDF version:-    

AGM Result 2007   

AGM Notice 2007   

Form of Proxy 2007   

Notice to Shareholders 2007